Marco Renoldi
Director/Board Member bei RespiNor AS
Profil
Marco Renoldi is currently the Director at RespiNor AS.
Previously, he worked as the Executive Director & Head-International Franchise at Amgen, Inc. from 2009 to 2012, and as the Chief Commercial Officer & Senior Vice President at Shionogi Ltd.
from 2012 to 2014.
From 2014 to present, he has been the Co-Chief Operating Officer at Nordic Nanovector ASA. Renoldi holds a graduate and doctorate degree from the University of Milan and an MBA from Fondazione IdI.
Aktive Positionen von Marco Renoldi
| Unternehmen | Position | Beginn |
|---|---|---|
RespiNor AS
 RespiNor AS Electronic Equipment/InstrumentsElectronic Technology RespiNor AS operates as a medical device company. The company is headquartered in Oslo, Norway. | Director/Board Member | - |
Ehemalige bekannte Positionen von Marco Renoldi
| Unternehmen | Position | Ende |
|---|---|---|
| THOR MEDICAL | Chief Operating Officer | 10.01.2022 |
Shionogi Ltd.
 Shionogi Ltd. Pharmaceuticals: MajorHealth Technology Part of Shionogi & Co., Ltd., Shionogi Ltd. is a British company that manufactures and distributes pharmaceutical products. The private company is based in London, UK. | Corporate Officer/Principal | 01.10.2014 |
| AMGEN INC. | Director/Board Member | 01.06.2012 |
Ausbildung von Marco Renoldi
| University of Milan | Doctorate Degree |
| Fondazione IdI | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| AMGEN INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Nordic Nanovector ASA
 Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Nordic Nanovector ASA is a biopharmaceutical company, which engages in the development, marketing, and sale of medical products and equipment for anticancer therapeutics for haematological cancers. The firm offers the Betalutin which is an antibody radionuclide conjugates for the treatment of non-Hodgkin lymphoma. It operates through the following geographical segments: Norway, Switzerland, and the United Kingdom. The company was founded by Roy Hartvig Larsen, Oyvind Sverre Bruland, and Jostein Dahle on July 2, 2009 and is headquartered in Oslo, Norway. | Health Technology |
Shionogi Ltd.
Shionogi Ltd. Pharmaceuticals: MajorHealth Technology Part of Shionogi & Co., Ltd., Shionogi Ltd. is a British company that manufactures and distributes pharmaceutical products. The private company is based in London, UK. | Health Technology |
RespiNor AS
RespiNor AS Electronic Equipment/InstrumentsElectronic Technology RespiNor AS operates as a medical device company. The company is headquartered in Oslo, Norway. | Electronic Technology |
